Trial Updates At ASCO: Approval Of Daratumumab In Combination With Revlimid Or Velcade & Dexamethasone

Robert Rifkin MD Of US Oncology Research Discusses Trial Updates At ASCO: Approval Of Daratumumab In Combination With Revlimid Or Velcade & Dexamethasone. Author: Annual-Meeting Added: 06/06/2019
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts